cosibelimab

cosibelimab · Checkpoint Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for cosibelimab, covering 2025-02-03 to 2026-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy [Phase 4]